Skip to main content
COFCO BIOTECHNOLOGY CO., LTD. logo

COFCO BIOTECHNOLOGY CO., LTD. — Investor Relations & Filings

Ticker · 000930 ISIN · CNE000000ZR7 LEI · 300300CSR7RNP1P1CP32 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,252 across all filing types
Latest filing 2019-08-09 Board/Management Inform…
Country CN China
Listing Shenzhen Stock Exchange 000930

About COFCO BIOTECHNOLOGY CO., LTD.

https://www.cofcotech.com

COFCO Biotechnology Co., Ltd. specializes in the deep processing of agricultural products, primarily corn, cassava, and other grains. The company operates as a major producer of fuel ethanol, edible alcohol, and starch-based products. Its portfolio includes a wide range of sweeteners such as fructose and glucose, as well as organic acids like citric acid and lactic acid. Additionally, the firm develops bio-based materials and biochemical products including amino acids and feed additives. Serving diverse sectors such as food and beverage, pharmaceuticals, and renewable energy, the company focuses on technological innovation in biotechnology to enhance resource efficiency and promote sustainable industrial applications. It maintains a significant presence in the global supply chain for bio-based chemicals and ingredients.

Recent filings

Filing Released Lang Actions
独立董事候选人声明（李世辉）
Board/Management Information Classification · 95% confidence The document is a detailed declaration by an independent director candidate of a company, confirming compliance with various legal and regulatory requirements for serving as an independent director. It includes statements about qualifications, independence, and adherence to relevant laws and regulations. There is no financial data, no report of financial performance, no voting results, no management changes, no earnings information, and no mention of any report publication. The content is a formal declaration related to board/management information, specifically about an independent director candidate's qualifications and compliance. Therefore, the most appropriate classification is Board/Management Information (MANG). The document length (5262 characters) supports it being a full declaration rather than a brief announcement or certification.
2019-08-09 Chinese
七届董事会2019年第五次临时会议决议公告
Board/Management Information Classification · 100% confidence The document is a detailed announcement of resolutions passed at the 2019 fifth extraordinary meeting of the seventh board of directors of 中粮生物化学(安徽)股份有限公司. It includes information about board meeting attendance, voting results on various proposals such as changes in company name, office address, amendments to the articles of association, appointment and resignation of directors and senior management, and adjustments to director allowances. It also contains biographies of newly appointed directors and senior management. The content focuses on board and management changes and related governance matters. There is no financial data, earnings information, or audit content. The document is not a report publication announcement but a formal announcement of board decisions and management appointments. Therefore, it fits the category of Board/Management Information (MANG).
2019-08-09 Chinese
独立董事提名人声明
Board/Management Information Classification · 95% confidence The document is a public statement from the board of directors nominating an individual as an independent director candidate. It includes detailed declarations about the nominee's qualifications, compliance with various regulatory requirements, and independence criteria. There is no financial data, earnings information, or report content. The document is an announcement related to board/management changes, specifically the nomination of a new independent director. Therefore, it fits the category of Board/Management Information (MANG). The document length is moderate and contains detailed statements rather than a brief announcement or a report publication notice.
2019-08-09 Chinese
关于调整外部非关联董事津贴的公告
Remuneration Information Classification · 95% confidence The document is an announcement from the board of directors of 中粮生物化学（安徽）股份有限公司 regarding the adjustment of external non-affiliated directors' allowances. It mentions the board meeting date, the proposal to increase the allowance, and that the proposal will be submitted to the shareholders' meeting for approval. There is no financial data, no detailed report, no audit information, no earnings data, and no regulatory certification. The document is a formal announcement about board/management compensation changes, specifically related to director remuneration. This fits best under Remuneration Information (DEF 14A) as it details compensation adjustments for directors.
2019-08-09 Chinese
关于修订《公司章程》部分条款的公告
Governance Information Classification · 95% confidence The document is an announcement from the board of directors of 中粮生物化学（安徽）股份有限公司 regarding amendments to the company's Articles of Association (公司章程). It details specific changes to various articles, including company name, business scope, share repurchase conditions, and board structure. The document states that these amendments were approved by the board and will be submitted to the shareholders' meeting for approval. There is no financial data, no audit or financial report, no earnings information, no voting results, and no mention of a meeting presentation or transcript. The document is a formal announcement of corporate governance changes, specifically amendments to the company's charter, which fits the category of Governance Information (CGR). The document length is about 5,000 characters, and it contains substantive content rather than just a notice of report publication or certification. Therefore, the best classification is Governance Information (CGR).
2019-08-09 Chinese
关于调整独立董事津贴的公告
Board/Management Information Classification · 95% confidence The document is an announcement from the board of directors regarding the adjustment of independent director allowances. It includes details about the decision made by the board, the rationale behind the adjustment, and the need for shareholder approval at a general meeting. There are no financial statements, audit results, or detailed financial data presented. The document is not a full report but an announcement of a board/management decision related to compensation. Therefore, it fits best under Board/Management Information (MANG). The document length is short and focused on management decisions rather than financial results or regulatory filings.
2019-08-09 Chinese

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.